San Francisco-based Carrum Health has recently completed a Series B funding round, raising $45 million. Led by OMERS Growth Equity and with participation from other prominent investors, this funding positions Carrum Health as a pioneer in healthcare innovation.
The company’s total funding now amounts to $85 million. The investment will allow Carrum Health to expand its oncology benefits and scale its surgical care service lines, bringing nationwide access to top doctors and empowering employers to manage healthcare spending more effectively.
Under the leadership of CEO Sach Jain, Carrum Health operates as a digital marketplace, revolutionizing the way self-funded employers procure bundled healthcare services.
The company’s primary focus lies in surgical and cancer care, aiming to deliver high-quality, value-based care. By efficiently coordinating and guiding patients through their surgical journey, Carrum Health provides an intuitive network navigation system for employers.
The Centers of Excellence (COE) Network
At the core of Carrum Health’s transformative approach is its Centers of Excellence (COE) network. This carefully curated network highlights high-quality surgical centers across the United States, ensuring exceptional healthcare options for patients and employers.
With the recent funding infusion, Carrum Health plans to strengthen its oncology benefits and expand its surgical care service lines, solidifying its commitment to delivering excellent care.
Carrum Health has established strategic partnerships with renowned cancer care providers, including AccessHope LLC, City of Hope, GRAIL LLC, Memorial Sloan Kettering Cancer Center, and University of Chicago Medicine.
Additionally, the company has expanded its network by collaborating with esteemed partners such as CVS, Included Health, Accolade, Rightway, SWORD Health, and Virgin Pulse.
Carrum Health’s steadfast commitment to high-quality care and cost reduction has fueled its remarkable growth, achieving 100 percent year-over-year growth in new customers and maintaining high customer retention rates.
Validation and Recognition
Carrum Health’s value-based care approach, especially in its oncology COE offering, has gained impressive momentum.
A validated RAND Corporation study confirms that the company’s approach eliminates unnecessary procedures by up to 30 percent, resulting in improved patient outcomes and potential savings of up to 45 percent per care episode.
Recognized within the industry, the health startup was honored as one of the best places to work in 2022 by Built In and included in the prestigious 2021 CB Insights Digital Health 150.
With the completion of its Series B funding round, Carrum Health is well-positioned to expand its offerings and solidify its position as a trailblazer in the healthcare industry.
This significant funding milestone propels Carrum Health towards its mission of revolutionizing healthcare, ensuring superior care, reducing costs, and achieving tangible results for employers and patients alike.